Differentiation of osteoblastin vitro is regulated by progesterone

Chen Lulu , Niels T. Foged

Current Medical Science ›› 1996, Vol. 16 ›› Issue (2) : 83 -86.

PDF
Current Medical Science ›› 1996, Vol. 16 ›› Issue (2) : 83 -86. DOI: 10.1007/BF02887963
Article

Differentiation of osteoblastin vitro is regulated by progesterone

Author information +
History +
PDF

Abstract

The regulation of cellular differentiation by progesterone in fetal rat calvarial osteoblasts was investigated. Our results showed that cells cultured in the presence of progesterone had a 7% increase in the alkaline phosphatase activity when compared to untreated cells. The concentration of osteocalcin in the conditioned medium from progesterone treated osteoblasts was 28 % higher than that of untreated controls. In addition, administration of progesterone significantly enhanced the number and area of bone nodules. In conclusion, progesterone stimulates the differentiation of fetal rat calvarial osteoblastic cellsin vitro

Keywords

fetal rat calvarial osteoblastic cells / progesterone / ALP activity / osteocalcin / bone nodule

Cite this article

Download citation ▾
Chen Lulu, Niels T. Foged. Differentiation of osteoblastin vitro is regulated by progesterone. Current Medical Science, 1996, 16(2): 83-86 DOI:10.1007/BF02887963

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

PeckW A, Barret-ConnorE, BuckwalterJ A, et al.. Osteoporosis. Concensus conference. JAMA, 1984, 10: 799-799

[2]

SlemendaS, HuiH L, LongscopeC, et al.. Sex steroids and bone mass: a study of changes about the time of menopause. J Clin Invest, 1987, 80: 1261-1261

[3]

JohnstonC C, NortonJ A, KhairiR A, et al.. BarzelU. S., et al.. Age-related Bone Loss. Osteoporosis II, 1978WuhanGrune & Stratton91-100

[4]

AlbdallaH I, HartD M, LindseyR, et al.. Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol, 1985, 66: 789-789

[5]

ChristiansenC, RiisB J, NilasL, et al.. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet, 1985, ii: 800-800

[6]

EriksenE F, ColvardD S, BergN J, et al.. Evidence of estrogen receptors in normal human osteoblast-like cells. Science, 1988, 241: 84-84

[7]

ChenL L, JørgenS, FogedN T. ALP induction by β-glycerophosphate during the non-mineralization phasein vitro. J Tongji Med Univ, 1996, 16(1): 20-20

[8]

BellowsC G, AubinJ E, HeerscheJ N M, et al.. Mineralized bone nodulesformedin vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int, 1986, 38: 143-143

[9]

SchevenB A A, DamenC A, HamiltonN J, et al.. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human psteoblast-like cellsin vitro. Biochem Biophys Res Commun, 1992, 186: 54-54

[10]

ChristiansenC, RiisB J. 17β-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab, 1990, 71: 836-836

AI Summary AI Mindmap
PDF

74

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/